申请人:Burroughs Wellcome Co.
公开号:US04590271A1
公开(公告)日:1986-05-20
Compounds of the formula (II) ##STR1## or a salt, N-oxide or acyl derivative thereof, wherein Y is a group ##STR2## which is linked to the pyrimidinylmethyl moiety at the 1 or 7-position and is optionally substituted at the 2, 3, 4 or 6-position or at the 7-position when the linkage to the pyrimidinylmethyl moiety is at the 1-position wherein X is an oxygen or sulphur atom, a group CH.sub.2, a group S(O).sub.n where n=1 or 2, a group NR.sup.1 wherein R.sup.1 is hydrogen C.sub.1-4 alkyl or a group COR.sup.2 where R.sup.2 is hydrogen, C.sub.1-4 alkoxy or amino and the dotted line represents a single or double bond, have antimicrobial activity. Processes for making these compounds, pharmaceutical compositions containing them and the medical use of the compounds are also disclosed.
化合物的公式(II)##STR1##或其盐,N-氧化物或酰基衍生物,其中Y是一个##STR2##的基团,它连接到嘧啶基甲基上的1或7位,并在2、3、4或6位或7位(当连接到嘧啶基甲基的位置为1位时)可选择地取代,其中X是氧或硫原子,CH.sub.2基团,S(O).sub.n基团,其中n = 1或2,NR.sup.1基团,其中R.sup.1是氢C.sub.1-4烷基或COR.sup.2基团,其中R.sup.2是氢,C.sub.1-4烷氧基或氨基,虚线表示单键或双键,具有抗微生物活性。还公开了制备这些化合物的方法,含有它们的制药组合物以及化合物的医疗用途。